The changing picture of amyotrophic lateral sclerosis: lessons from European registers
Open accessThe DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Abstract
Prospective population based-registers of amyotrophic lateral sclerosis (ALS) have operated in Europe for over two decades, and have provided important insights into our understanding of ALS. Here, we review the benefits that population registers have brought to the understanding of the incidence, prevalence, phenotype and genetics of ALS and outline the core operating principles that underlie these registers and facilitate international collaboration. Going forward, we offer lessons learned from our collective experience of operating population-based ALS registers in Europe for over two decades, focusing on register design, maintenance, identification and management of bias and the value of cross-national harmonisation and integration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and is particularly high in Europe, with 15,000 new cases per year [20], [21].”
From Hands-Free Accessible Digital Musical Instruments: Conceptual Framework, Challenges, and Perspectives (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prevalence ranges from 4 to 9 people per 100,000 [19] [21].”
From Hands-Free Accessible Digital Musical Instruments: Conceptual Framework, Challenges, and Perspectives (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hall, W. J., Chapman, M. V., Lee, K. M., Merino, Y. M., Thomas, T. W., Payne, B. K., Eng, E., Day, S. H., & Coyne-Beasley, T. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302903 · Cited by 2,176
Majounie, E., Renton, A. E., Mok, K., Dopper, E. G., Waite, A., Rollinson, S., Chiò, A., Restagno, G., Nicolaou, N., Simon-Sanchez, J., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70043-1 · Cited by 1,210 · cited 1×
“Variation in the prevalence of at risk genes is known to be the case for at least two major ALS genes - the frequency of the C9orf72 repeat expansion is high in populations of European extraction and low in the Asian population [44], while variants in SOD1 account for 13% of familial ALS in Italy, but are not found in…”
BackgroundSelf-citationChiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862 · cited 3×
“However, careful evaluation of European Register data collected over 20 years suggest otherwise[14].”
BackgroundSelf-citationIncidence of amyotrophic lateral sclerosis in Europe
Logroscino, G., Traynor, B. J., Hardiman, O., Chio, A., Mitchell, D., Swingler, R. J., Millul, A., Benn, E., Beghi, E., & EURALS, F. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.183525 · Cited by 772 · cited 5×
“6/100,000 personyears and prevalence rates of 7-9/100,000 persons, with a mean life expectancy of 30 months from first symptoms[2,12,13].”
BackgroundInfluentialSelf-citationThe syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study
Phukan, J., Elamin, M., Bede, P., Jordan, N., Gallagher, L., Byrne, S., Lynch, C., Pender, N., & Hardiman, O. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300188 · Cited by 667
Self-citationCruz-Flores, S., Rabinstein, A., Biller, J., Elkind, M. S. V., Griffith, P., Gorelick, P. B., Howard, G., Leira, E. C., Morgenstern, L. B., Ovbiagele, B., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182213e24 · Cited by 507 · cited 1×
“Differences in ancestral risk may be significant sources of bias in the generation of Registers in countries such as the US, where differential access to and utilization of health services is linked to race, ethnicity, language, rurality, and socioeconomic status [51,52].”
BackgroundByrne, S., Elamin, M., Bede, P., Shatunov, A., Walsh, C., Corr, B., Heverin, M., Jordan, N., Kenna, K., Lynch, C., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70014-5 · Cited by 484
Self-citationDescriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues
Logroscino, G., Traynor, B. J., Hardiman, O., Chio', A., Couratier, P., Mitchell, J. D., Swingler, R. J., Beghi, E., & EURALS, F. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.104828 · Cited by 448
Self-citationAnalysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
Al-Chalabi, A., Calvo, A., Chio, A., Colville, S., Ellis, C. M., Hardiman, O., Heverin, M., Howard, R. S., Huisman, M. H. B., Keren, N., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70219-4 · Cited by 411 · cited 1×
“For example, combined appraisal of Registers has indicated the presence of population based variability, has provided evidence that ALS is a multistep process[5], and has facilitated unbiased studies of spatial epidemiology[9–11].”
BackgroundSelf-citationRate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis
Byrne, S., Walsh, C., Lynch, C., Bede, P., Elamin, M., Kenna, K., McLaughlin, R., & Hardiman, O. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.224501 · Cited by 351
Self-citationMultidisciplinary ALS care improves quality of life in patients with ALS
Van den Berg, J. P., Kalmijn, S., Lindeman, E., Veldink, J. H., de Visser, M., Van der Graaff, M. M., Wokke, J. H. J., & Van den Berg, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000180717.29273.12 · Cited by 343
Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis
Marin, B., Boumédiene, F., Logroscino, G., Couratier, P., Babron, M.-C., Leutenegger, A. L., Copetti, M., Preux, P.-M., & Beghi, E. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw061 · Cited by 325 · cited 1×
“As noted, there is now considerable evidence that the incidence of ALS varies significantly across countries [47,48] and the phenotype and outcome of the disease vary in relation to population ancestral origin [49].”
BackgroundSelf-citationExecutive dysfunction is a negative prognostic indicator in patients with ALS without dementia
Elamin, M., Phukan, J., Bede, P., Jordan, N., Byrne, S., Pender, N., & Hardiman, O. (2011) · Neurology · doi:10.1212/wnl.0b013e318214359f · Cited by 301 · cited 1×
“For example, Irish and Italian Registers have shown that cognitive and behavioural changes are intrinsic features of ALS, affecting up to 50% of patients[28], and are associated with significant prognostic implications [29,30].”
BackgroundSelf-citationNEK1 variants confer susceptibility to amyotrophic lateral sclerosis
SLAGEN Consortium, Kenna, K. P., van Doormaal, P. T. C., Dekker, A. M., Ticozzi, N., Kenna, B. J., Diekstra, F. P., van Rheenen, W., van Eijk, K. R., Jones, A. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3626 · Cited by 287 · cited 1×
“For example, higher rates of ALS have been identified in a population isolate in The Netherlands, leading to the discovery of ALS associated variants in the NEK1 gene [3].”
BackgroundSelf-citationCognitive changes predict functional decline in ALS: A population-based longitudinal study
Elamin, M., Bede, P., Byrne, S., Jordan, N., Gallagher, L., Wynne, B., O’Brien, C., Phukan, J., Lynch, C., Pender, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828f18ac · Cited by 272 · cited 1×
“For example, Irish and Italian Registers have shown that cognitive and behavioural changes are intrinsic features of ALS, affecting up to 50% of patients[28], and are associated with significant prognostic implications [29,30].”
BackgroundSelf-citationFTD and ALS: A Tale of Two Diseases
Ferrari, R., Kapogiannis, D., D. Huey, E., & Momeni, P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563700 · Cited by 272
Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology
Huisman, M. H. B., de Jong, S. W., van Doormaal, P. T. C., Weinreich, S. S., Schelhaas, H. J., van der Kooi, A. J., de Visser, M., Veldink, J. H., & van den Berg, L. H. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.244939 · Cited by 270 · cited 2×
“To assess the degree of under-ascertainment when two or more independent sources are used, a capture-recapture system is often used [13,15], although this is less accurate if data sources are linked in any way as has been shown by the Irish Register[16].”
BackgroundMethodEpidemiology of ALS in Italy: A 10-year prospective population-based study
Chiò, A., Mora, G., Calvo, A., Mazzini, L., Bottacchi, E., & Mutani, R. (2009) · Neurology · doi:10.1212/01.wnl.0000343008.26874.d1 · Cited by 255
Chio, A. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.083402 · Cited by 232
Rooney, J., Byrne, S., Heverin, M., Tobin, K., Dick, A., Donaghy, C., & Hardiman, O. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309601 · Cited by 225
Self-citationThe epidemiology of ALS and the role of population-based registries
Beghi, E., Logroscino, G., Chiò, A., Hardiman, O., Mitchell, D., Swingler, R., & Traynor, B. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.09.008 · Cited by 200 · cited 3×
“Introduction Prospectively designed population based registers with complete ascertainment of all affected individuals in a defined geographic catchment area are of increasing value in epidemiologic research, as evidenced by the success of European population-based registers for Amyotrophic Lateral Sclerosis (ALS)[1,2…”
BackgroundSelf-citationEpidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004
O'Toole, O., Traynor, B. J., Brennan, P., Sheehan, C., Frost, E., Corr, B., & Hardiman, O. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.117788 · Cited by 197
Self-citationBerger, M. L., Dreyer, N., Anderson, F., Towse, A., Sedrakyan, A., & Normand, S.-L. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.010 · Cited by 189
An outcome study of riluzole in amyotrophic lateral sclerosis
Traynor, B. J., Alexander, M. D., Corr, B., Frost, E., & Hardiman, O. M. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1026-z · Cited by 176
Self-citationDelineating the genetic heterogeneity of ALS using targeted high-throughput sequencing
Kenna, K. P., McLaughlin, R. L., Byrne, S., Elamin, M., Heverin, M., Kenny, E. M., Cormican, P., Morris, D. W., Donaghy, C. G., Bradley, D. G., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101795 · Cited by 170
Self-citationFranchignoni, F., Mora, G., Giordano, A., Volanti, P., & Chiò, A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304701 · Cited by 166
Lifetime physical activity and the risk of amyotrophic lateral sclerosis
Huisman, M. H. B., Seelen, M., de Jong, S. W., Dorresteijn, K. R. I. S., van Doormaal, P. T. C., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., van den Berg, L. H., & Veldink, J. H. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304724 · Cited by 156
Marin, B., Logroscino, G., Boumédiène, F., Labrunie, A., Couratier, P., Babron, M., Leutenegger, A., Preux, P., & Beghi, E. (2015) · European Journal of Epidemiology · doi:10.1007/s10654-015-0090-x · Cited by 146
Self-citationReduced frequency of ALS in an ethnically mixed population: A population-based mortality study
Zaldivar, T., Gutierrez, J., Lara, G., Carbonara, M., Logroscino, G., & Hardiman, O. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a55f7b · Cited by 135 · cited 3×
“South American populations of mixed ancestral origin may have lower rates of ALS compared with those reported in Europe [47,50].”
BackgroundResultSelf-citation(2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70037-1 · Cited by 132 · cited 1×
“the South-East England ALS (SEALS) register[25].”
Byrne, S., Heverin, M., Elamin, M., Bede, P., Lynch, C., Kenna, K., MacLaughlin, R., Walsh, C., Al Chalabi, A., & Hardiman, O. (2013) · Annals of Neurology · doi:10.1002/ana.23969 · Cited by 130
Self-citationFactors predicting survival in ALS: a multicenter Italian study
Calvo, A., Moglia, C., Lunetta, C., Marinou, K., Ticozzi, N., Ferrante, G. D., Scialo, C., Sorarù, G., Trojsi, F., Conte, A., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-016-8313-y · Cited by 122
Self-citationCluster analysis and disease mapping—why, when, and how? A step by step guide
Olsen, S. F., Martuzzi, M., & Elliott, P. (1996) · BMJ · doi:10.1136/bmj.313.7061.863 · Cited by 120
de Jong, S. W., Huisman, M. H. B., Sutedja, N. A., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., Fischer, K., Veldink, J. H., & van den Berg, L. H. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws015 · Cited by 117
ALS clinical trials: Do enrolled patients accurately represent the ALS population?
Chiò, A., Canosa, A., Gallo, S., Cammarosano, S., Moglia, C., Fuda, G., Calvo, A., Gabriele, M., & For the PARALS group (2011) · Neurology · doi:10.1212/wnl.0b013e318232ab9b · Cited by 114
Huisman, M. H. B., Seelen, M., van Doormaal, P. T. C., de Jong, S. W., de Vries, J. H. M., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., van den Berg, L. H., & Veldink, J. H. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1584 · Cited by 104
Increasing incidence of ALS in Canterbury, New Zealand: A 22-year study
Murphy, M., Quinn, S., Young, J., Parkin, P., & Taylor, B. (2008) · Neurology · doi:10.1212/01.wnl.0000336653.65605.ac · Cited by 95
What we truly know about occupation as a risk factor for ALS: A critical and systematic review
Sutedja, N. A., Fischer, K., Veldink, J. H., van der Heijden, G. J. M. G., Kromhout, H., Heederik, D., Huisman, M. H. B., Wokke, J. J. H., & van den Berg, L. H. (2009) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482960802430799 · Cited by 92
Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study
Chiò, A., Calvo, A., Moglia, C., Gamna, F., Mattei, A., Mazzini, L., Mora, G., & PARALS, A. T. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300472 · Cited by 91
Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010
Rooney, J., Byrne, S., Heverin, M., Corr, B., Elamin, M., Staines, A., Goldacre, B., & Hardiman, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074733 · Cited by 84 · cited 3×
“How biases in datasets can affect survival estimates Population based Registers have demonstrated that up to 70% of patients with ALS die within 3 years of first symptoms, and that approximately 5-10% can survive for more than 8 years[12,23].”
BackgroundSelf-citationALS multidisciplinary clinic and survival
Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Guerra, V., Lepore, V. L., Simone, I. L., Lamberti, P., Serlenga, L., & Logroscino, G. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0401-y · Cited by 74
Self-citationGenetic architecture of ALS in Sardinia
Borghero, G., Pugliatti, M., Marrosu, F., Marrosu, M. G., Murru, M. R., Floris, G., Cannas, A., Parish, L. D., Occhineri, P., Cau, T. B., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.012 · Cited by 72
The costs of amyotrophic lateral sclerosis, according to type of care
van der Steen, I., van den Berg, J., Buskens, E., Lindeman, E., & van den Berg, L. H. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802103131 · Cited by 57
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009
Pugliatti, M., Parish, L. D., Cossu, P., Leoni, S., Ticca, A., Saddi, M. V., Ortu, E., Traccis, S., Borghero, G., Puddu, R., et al. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6681-5 · Cited by 53
Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
Zach, N., Ennist, D. L., Taylor, A. A., Alon, H., Sherman, A., Kueffner, R., Walker, J., Sinani, E., Katsovskiy, I., Cudkowicz, M., et al. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0336-z · Cited by 46
Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study
Georgoulopoulou, E., Vinceti, M., Bonvicini, F., Sola, P., Goldoni, C. A., Girolamo, G. D., Ferraro, D., Nichelli, P., & Mandrioli, J. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.593037 · Cited by 45
Galvin, M., Madden, C., Maguire, S., Heverin, M., Vajda, A., Staines, A., & Hardiman, O. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1229-x · Cited by 45
Self-citationGeographical Clustering of Amyotrophic Lateral Sclerosis in South-East England: A Population Study
Scott, K. M., Abhinav, K., Stanton, B. R., Johnston, C., Turner, M. R., Ampong, M.-A., Sakel, M., Orrell, R. W., Howard, R., Shaw, C. E., et al. (2009) · Neuroepidemiology · doi:10.1159/000177032 · Cited by 40
Self-citationIncidence of Amyotrophic Lateral Sclerosis in the Local Health District of Ferrara, Italy, 1964–1998
Govoni, V., Granieri, E., Capone, J. G., Manconi, M., & Casetta, I. (2003) · Neuroepidemiology · doi:10.1159/000070563 · Cited by 34
Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009–2011
Henry, K., Fagliano, J. A., Jordan, H. M., Rechtman, L., & Kaye, W. (2015) · American Journal of Epidemiology · doi:10.1093/aje/kwv095 · Cited by 32 · cited 2×
“For example, an association between ALS with area-based socio-economic status was reported in New Jersey,37 where access to health services is not uniform and those in lower socio-economic groups may not be captured.”
BackgroundVlam, L., Piepers, S., Sutedja, N. A., Jacobs, B. C., Tio‐Gillen, A. P., Stam, M., Franssen, H., Veldink, J. H., Cats, E. A., Notermans, N. C., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7612-4 · Cited by 30
Bucheli, M. E., Andino, A., Montalvo, M., Cruz, J., Atassi, N., Berry, J. D., & Salameh, J. S. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.852590 · Cited by 28
Tesauro, M., Consonni, M., Filippini, T., Mazzini, L., Pisano, F., Chiò, A., Esposito, A., & Vinceti, M. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1281961 · Cited by 28
Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases
Migliaretti, G., Berchialla, P., Dalmasso, P., Cavallo, F., & Chiò, A. (2012) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2012.733401 · Cited by 27
Critical issues in ALS case-control studies: the case of the Euro-MOTOR study
D’Ovidio, F., Rooney, J. P. K., Visser, A. E., Vermeulen, R. C. H., Veldink, J. H., van den Berg, L. H., Hardiman, O. M., Logroscino, G., Chiò, A., Beghi, E., et al. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1285939 · Cited by 27 · cited 2×
“The Euro-MOTOR project has now established a repository of over 1500 population based incident cases and 3000 matched controls with extensive phenotype, environmental, and genomic characterization[36].”
BackgroundMethodSelf-citationSpatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland
Rooney, J. P. K., Vajda, A., Heverin, M., Elamin, M., Crampsie, A., McLaughlin, R. L., Staines, A. S., & Hardiman, O. M. (2015) · Neurology · doi:10.1212/wnl.0000000000001477 · Cited by 26 · cited 3×
“A region of reduced incidence (‘cold spot’) has recently been reported by the Irish Register.40 The reasons for this are unclear but may be related to subtle historical differences in local population structure.”
BackgroundSelf-citationValidating population-based registers for ALS: how accurate is death certification?
Yeo, L., Lynch, C. M., & Hardiman, O. M. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5494-7 · Cited by 26 · cited 3×
“A region of reduced incidence (‘cold spot’) has recently been reported by the Irish Register.40 The reasons for this are unclear but may be related to subtle historical differences in local population structure.”
MethodSelf-citationAge-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence
Tobin, K., Gilthorpe, M. S., Rooney, J. P. K., Heverin, M., Vajda, A., Staines, A. S., & Hardiman, O. M. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8215-z · Cited by 22
Self-citationRooney, J. P. K., Tobin, K., Crampsie, A., Vajda, A., Heverin, M., McLaughlin, R. L., Staines, A. S., & Hardiman, O. M. (2015) · Environmental Research · doi:10.1016/j.envres.2015.06.024 · Cited by 15
Self-citation
Cited by
Hardiman, O., Al-Chalabi, A., Chio, A., Corr, E. M., Logroscino, G., Robberecht, W., Shaw, P. J., Simmons, Z., & van den Berg, L. H. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.71 · Cited by 1,414
Self-citationEpidemiology of amyotrophic lateral sclerosis: an update of recent literature
Longinetti, E., & Fang, F. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000730 · Cited by 620
Westeneng, H.-J., Debray, T. P. A., Visser, A. E., van Eijk, R. P. A., Rooney, J. P. K., Calvo, A., Martin, S., McDermott, C. J., Thompson, A. G., Pinto, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30089-9 · Cited by 524
Self-citationNEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found?
An, H., Williams, N. G., & Shelkovnikova, T. A. (2018) · Non-coding RNA Research · doi:10.1016/j.ncrna.2018.11.003 · Cited by 162
Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
Volk, A. E., Weishaupt, J. H., Andersen, P. M., Ludolph, A. C., & Kubisch, C. (2018) · Medizinische Genetik · doi:10.1007/s11825-018-0185-3 · Cited by 156
“In Europe, the incidence is about 2–3 per 100,000 individuals [19].”
Background
Metadata
- Authors
- Hardiman, O., Al-Chalabi, A., Brayne, C., Beghi, E., van den Berg, L. H., Chio, A., Martin, S., Logroscino, G., & Rooney, J.
- Affiliations
- Trinity College Dublin (IE)
- University of Cambridge (GB)
- University of Bari Aldo Moro (IT)
- Corresponding author
- Hardiman, Orla
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2017-03-11
- Volume
- 88
- Issue
- 7
- Pages
- 557-563
- ISSN
- 0022-3050 (ISSN-L)
- 1468-330X
- OpenAlex
- W2594396441
- Cited by
- 126
- References
- 61
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 7 · 2023: 7 · 2022: 12 · 2021: 23 · 2020: 20 · 2019: 17 · 2018: 11 · 2017: 8
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- HighWire Press Open Archive (submittedVersion)
- Apollo
- Funders
- Seventh Framework Programme
- Health Research Board
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- amyotrophic lateral sclerosis, population-based registers, incidence, prevalence, ALS phenotypes, ALS genetics, register design, international cooperation
- MeSH terms
- Amyotrophic Lateral Sclerosis, Ethnicity, Europe, Humans, Phenotype, Population Surveillance, Prospective Studies, Registries, Risk Factors, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.